SGLT-2 Inhibitors: Discrepancy Between MACE Reduction and Incident MI and Stroke

J Clin Endocrinol Metab. 2023 Oct 18;108(11):e1450-e1451. doi: 10.1210/clinem/dgad216.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2*
  • Humans
  • Hypoglycemic Agents
  • Myocardial Infarction*
  • Sodium-Glucose Transporter 2 Inhibitors* / adverse effects
  • Stroke* / epidemiology
  • Stroke* / etiology
  • Stroke* / prevention & control

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Hypoglycemic Agents